TMS Co (TSE:4891) Other Current Payables: 円16.35 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4891 TMS Co Ltd TSE:4891
32 GF Score
Price 円100.00
! 1 Warning Sign
View Full Analysis

What is TMS Co Other Current Payables?

TMS Co TSE:4891 32 Other Current Payables is 円16.35 Mil as of Dec. 2025. GuruFocus rates TSE:4891 with a GF Score™ of 32/100. The stock has 1 warning sign investors should review.

TMS Co's Other Current Payables for the quarter that ended in Dec. 2025 was 円16.35 Mil.

TMS Co's quarterly Other Current Payables declined from May. 2025 (円37.77 Mil) to Aug. 2025 (円12.21 Mil) but then increased from Aug. 2025 (円12.21 Mil) to Dec. 2025 (円16.35 Mil).

TMS Co's annual Other Current Payables increased from Feb. 2023 (円28.69 Mil) to Feb. 2024 (円32.85 Mil) and increased from Feb. 2024 (円32.85 Mil) to Feb. 2025 (円90.94 Mil).

TMS Co Other Current Payables Related Terms

TMS Co Other Current Payables Historical Data

* Premium members only.

The historical data trend for TMS Co's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TMS Co Other Current Payables Chart

TMS Co Annual Data
Trend Feb21 Feb22 Feb23 Feb24 Feb25
Other Current Payables
9.18 168.96 28.69 32.85 90.94

TMS Co Quarterly Data
Feb21 Feb22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Feb25 May25 Aug25 Dec25
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.08 90.94 37.77 12.21 16.35
TSE:4891
32GF Score
TMS Co Ltd TSE:4891
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TMS Co Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of 円16.35 Mil mean?
TMS Co (TSE:4891) has a Other Current Payables of 円16.35 Mil as of Dec. 2025. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on TMS Co and its competitors.
Is TMS Co's Other Current Payables too high?
TMS Co's current Other Current Payables is 円16.35 Mil. Overall, TMS Co has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does TMS Co's Other Current Payables compare to VRTX and REGN?
TMS Co's Other Current Payables of 円16.35 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Biotechnology company?
A good Other Current Payables depends on the Biotechnology industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on TMS Co and its competitors. TMS Co's current Other Current Payables is 円16.35 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TMS Co stock overvalued right now?
TMS Co (TSE:4891) has a current Other Current Payables of 円16.35 Mil. The current Other Current Payables is 円16.35 Mil. TMS Co's overall GF Score™ is 32/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For TMS Co (TSE:4891), the current Other Current Payables is 円16.35 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TMS Co Business Description

Address 1-9-11F, Fuchu-cho, Fuchu-shi, Tokyo, JPN, 183-0055
TMS Co Ltd is focused on researching, developing, manufacturing, and selling pharmaceuticals. The company is involved in conducting research and development of SMTP compounds, which are drug candidate substances targeting soluble epoxide hydrolase (sEH), an enzyme found in the human body. It is developing sEH inhibitors for various inflammatory diseases. The company's clinical pipeline comprises three compounds: TMS-007 (being developed as a potential treatment for acute cerebral infarction), which is in the late clinical stage, TMS-010, and JX09 (for resistant and poorly controlled hypertension) and TMS-008 (to target acute inflammatory diseases such as kidney injury and cancer cachexia), which are in the early clinical stage. In addition, it has TMS-009 as a backup compound for TMS-008.
32GF Score

Get the complete analysis for TSE:4891

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円100.00
Price